Aradigm Corporation Enters Sublease Agreement with Mendel Biotechnology
Memo: Leasing News
Aegis Realty Partners Press Release
For Immediate Release
July 23, 2007
Aradigm Corporation Enters Sublease Agreement with Mendel Biotechnology
Hayward, CA — July 23, 2007 – Aradigm Corp., a specialty pharmaceutical company, has subleased approximately 54,000 square feet in its headquarters facility located at 3929 Point Eden Way in Hayward, to Mendel Biotechnology. The multi-year, renewable agreement commenced July 18th, 2007. Scott Stone and Garrett Krueger of Aegis Realty Partners worked on behalf of Aradigm to sublease a portion of their existing space after a corporate restructuring. Aradigm will continue to occupy a portion of the facility and sustain all operations. The subtenant, Mendel Biotechnology, is a plant biotechnology company which required improved space to accommodate expansion tied to a recent funding event. Mendel Biotechnology was represented by Bob Ferraro and Mark Kol of CB Richard Ellis in Oakland.
“We are delighted to have reached an agreement with Mendel Biotechnology and to share a first-class facility with them,” said Dr. Igor Gonda, Aradigm’s President and CEO. “Importantly, we are able to accomplish this without the need for relocation and with no material disruption to our operations.”
About AEGIS:
Oakland-based Aegis Realty Partners is a full service commercial real estate brokerage firm. Aegis has represented clients in transactions totaling over 2.8 million square feet, and is unique among real estate brokerage firms for its focus on tenant representation. For more information about Aegis, please visit the company’s website at www,aegisrealty.com.
Contact Information
Jessica Stewart
Aegis Realty Partners
510.273.2012
Jessica@aegisrealty.com
www.aegisrealty.com
For more information about Aradigm Corporation, go to www.aradigm.com
For more information about Mendel Biotechnology, go to www.mendelbio.com



